Search Hill Dickinson

Hill Dickinson advises Hilltop Leaf on second successful fundraise

Hill Dickinson advises Hilltop Leaf on second successful fundraise

Law firm Hill Dickinson has advised Scotland’s first medical cannabis production facility on a £2 million fundraise from UK investment house Traditum Private Equity and a number of private investors.

The funding enables Hilltop Leaf to scale its infrastructure for the specialist prescription market and to begin commercial sales. It follows an initial seed capital investment round in May 2021 (on which Hill Dickinson also advised Hilltop Leaf), which exceeded its £2 million target.

James Paton-Philip, a partner in Hill Dickinson’s London Corporate team provided legal advice to Hilltop Leaf, assisted by senior associate Terry Ko and apprentice solicitor Rianne Byott.

He said: “We are pleased to have advised Hilltop Leaf on this significant milestone in the company’s growth, just as the regulations that currently restrict the wider prescription of medical cannabis to patients in the UK and Europe are beginning to ease.”

Hilltop Leaf was founded in 2019 by entrepreneur Hamish Clegg, together with father and son Neil and Will Ewart who have a track record in windfarms and agriculture. It operates from an 11,000 sq m production facility in southern Scotland and will produce pharmaceutical-grade cannabis-based products for medicinal use in humans (CBPMs) which will ultimately be processed on site. 
 

Corporate

Delivering a high-quality combination of technical expertise, commercial acumen and excellent client service, our clients value the quality of our people, our market knowledge and our commitment to achieving success for them. We always aim to exceed their expectations.

Our highly experienced and recognised corporate team operates from our offices in Liverpool, Manchester, London, Leeds, Hong Kong and Singapore. We offer our clients accessible corporate support from our experienced national and international network and specialise in advising a range of clients, from large listed companies and private equity funds to smaller start-up and owner-managed businesses and management teams on the full range of transactions – both domestic and cross-border. Our advice is distinctly commercial and focused on our clients’ commercial goals.

We work in small partner-led teams, providing our clients with easy access to our partners on transactions. We offer an innovative approach to managing client relationships and fee arrangements, which sets us apart from many of our competitors. We are able to offer our clients a timely, relevant and cost-effective service, that adds real value to the transaction process.